Food and Drug Administration: Difference between revisions
mNo edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
[[Image:fda-logo.jpg|right|thumb]] | [[Image:fda-logo.jpg|right|thumb]] | ||
The American Food and Drug Administration has approved several circumcision devices and products made from harvested infant foreskins.<ref name='fda-accucirc'>{{ | The American Food and Drug Administration has approved several circumcision devices and products made from harvested infant foreskins.<ref name='fda-accucirc'>{{REFweb | ||
| last=Brogdon | | last=Brogdon | ||
| first=Nancy C. | | first=Nancy C. | ||
| Line 7: | Line 7: | ||
| work= | | work= | ||
| date=2007-09-07 | | date=2007-09-07 | ||
| | | title=Dear Mr. Wallace | ||
| url=http://www.accucirc.com/documents/AccuCirc_510k.pdf | | url=http://www.accucirc.com/documents/AccuCirc_510k.pdf | ||
| accessdate=2011-03-06 | | accessdate=2011-03-06 | ||
}}</ref><ref name='fda-dermagraft-tc'>{{ | }}</ref><ref name='fda-dermagraft-tc'>{{REFweb | ||
| quote=...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA. | | quote=...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA. | ||
| last= | | last= | ||
| Line 17: | Line 17: | ||
| work= | | work= | ||
| date= | | date= | ||
| | | title=Dermagraft-TC | ||
| url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation | | url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation | ||
| accessdate= | | accessdate= | ||
}}</ref><ref name='fda-apligraf'>{{ | }}</ref><ref name='fda-apligraf'>{{REFweb | ||
| quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998). | | quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998). | ||
| last= | | last= | ||
| Line 27: | Line 27: | ||
| work= | | work= | ||
| date= | | date= | ||
| | | title=Apligraf | ||
| url=http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html | | url=http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html | ||
| accessdate=2011-03-06 | | accessdate=2011-03-06 | ||
}}</ref><ref name='fda-alloderm'>{{ | }}</ref><ref name='fda-alloderm'>{{REFweb | ||
| quote=...screened and tested according to FDA regulations... | | quote=...screened and tested according to FDA regulations... | ||
| last= | | last= | ||
| Line 37: | Line 37: | ||
| work= | | work= | ||
| date= | | date= | ||
| | | title=AlloDerm®Tissue Matrix defined | ||
| url=http://www.lifecell.com/alloderm-regenerative-tissue-matrix/95/ | | url=http://www.lifecell.com/alloderm-regenerative-tissue-matrix/95/ | ||
| accessdate=2011-03-06 | | accessdate=2011-03-06 | ||